Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe NIH banner about its terminology transition is no longer displayed above the 403 Forbidden study-record page.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedA general NIH banner announces a transition in NIH website content and says that “Super Intelligence” may appear in place of “Artificial Intelligence.” It appears above the unavailable study record.SummaryDifference1%

- Check35 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site footer revision advances from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.